The Utilization of Medication for Opioid Use Disorder in an Outpatient Setting-Presentation Slides

Presentation Slides

Pdf Summary

This document appears to be a presentation or transcript of a webinar on the utilization of medication for opioid use disorder in an outpatient setting. The webinar was part of an initiative by the American Psychiatric Association (APA) and the Substance Abuse and Mental Health Services Administration (SAMHSA). The document includes information on the Clinical Support System for Serious Mental Illness (CSS-SMI), continuing education credits, faculty members, and disclosures.<br /><br />The content of the document covers a range of topics related to opioid use disorder and its treatment. It highlights the increasing rates of opioid overdose deaths, the statistics on illicit drug use and the sources of pain relievers, and the co-occurring diagnoses often seen with opioid use disorder, such as anxiety-related disorders, depression-related disorders, ADHD, PTSD, and schizophrenia. The document also discusses the risk factors for opioid use disorder, the screening tools and techniques used, and the various medications for opioid use disorder, including methadone, buprenorphine, and naltrexone.<br /><br />The document provides information on the ASAM criteria for determining the level of care for patients with addiction and co-occurring disorders, as well as the importance of naloxone administration in cases of opioid overdose. It emphasizes the need to address the stigma surrounding opioid use disorder and the importance of using appropriate language when discussing the condition.<br /><br />The document concludes with information on how to claim continuing education credits for the webinar and announces an upcoming webinar on dialectical behavior therapy for serious and persistent mental illness.<br /><br />Please note that the summary provided is based on the content headings and does not include the specific details or discussions within each section.

Keywords

medication

opioid use disorder

outpatient setting

Clinical Support System for Serious Mental Illness

co-occurring diagnoses

screening tools

methadone

buprenorphine

naltrexone

naloxone administration